Skip to main content

4 Result(s)

within D. Bellanger Remove this filter

and

  1. No Access

    Article

    Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling

    T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive neoplasm of mature T-cells with an urgent need for rationally designed therapies to address its notoriously chemo-refractory behavior. The median...

    E I Andersson, S Pützer, B Yadav, O Dufva, S Khan, L He, L Sellner, A Schrader… in Leukemia (2018)

  2. No Access

    Article

    Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia

    D Bellanger, V Jacquemin, M Chopin, G Pierron, O A Bernard, J Ghysdael… in Leukemia (2014)

  3. No Access

    Article

    MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor

    Ewing sarcoma is a pediatric bone tumor characterized in 85% of cases by the fusion between EWS and FLI1 genes that results in the expression of the EWS-FLI1 aberrant transcription factor. Histologically, the Ewi...

    G-A Franzetti, K Laud-Duval, D Bellanger, M-H Stern, X Sastre-Garau, O Delattre in Oncogene (2013)

  4. No Access

    Article

    Tissue attachment strength of prosthetic meshes used in ventral and incisional hernia repair

    Background: Many prosthetic materials are used in incisional hernia repair, including polypropylene (PP) and expanded polytetrafluoroethylene (ePTFE). However, PP forms severe adhesions and ePTFE has raised co...

    K.A. LeBlanc, D. Bellanger, K.V. Rhynes, D.G. Baker, R.W. Stout in Surgical Endoscopy (2002)